SAVE MONEY ON TRAVEL DEALS

Researchers at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center said women derive a lesser benefit than men from the two common high-blood pressure-lowering drugs for the reduction of left-ventricular hypertrophy. The condition is a thickening and enlargement of muscle of the left ventricle of the heart and a marker for future heart disease. The observations were made despite results showing that blood pressure reduction was similar between genders.

The findings might explain how this underlying condition puts women at greater risk for heart disease later in life.

"Women have a greater chance of dying of their first heart attack and from stroke, and they tend to have more cardiovascular problems later in life compared with men", lead author Dr. Peter M. Okin, a cardiologist at NewYork-Presbyterian/Weill Cornell said in a statement.

The study and accompanying editorial were published in Hypertension, the journal of the American Heart Association.

 BREAKING STORIES

New law puts mental, physical ills on par

Cervical cancer shot gains acceptance

Study: Ginkgo can prevent stroke damage

WHO probes deadly mystery illness

Claim: Magic Johnson 'faked' AIDS

Exercise intervention helps with arthritis

WHO: Mental health stigma unfair

Official: Russia has no melamine victims

Bird flu survival tied to hands-on therapy

TV star to wed after getting cancer news

NSAIDs linked to lower breast cancer risk

Kids' asthma diagnosis can be a challenge

Herb may help curb bad breath

New procedure to correct sagging breasts

Why pizza may cause women pain, urination

Cocoa powder high in anti-oxidants

Genetic code of malaria parasite sequenced

Hormone reduces heart attack damage

Child cancer survivors face health issues

CDC: U.S. teen vaccination rate higher